Early Immunosuppression in Children and Adolescents with Crohn’s Disease
DATA FROM THE CEDATA GPGE REGISTRY To date, failure of the first-line medical management of Crohn’s disease (CD) in children and adolescents has been followed by escalation treatment, with administration of immunomodulators, e.g., azathioprine, or biologics, such as infliximab (1). The most recent revision of the international guideline proposes stratification Weiterlesen